This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antignac, A.
Right arrow Articles by Taha, M.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antignac, A.
Right arrow Articles by Taha, M.-K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2001, p. 3625-3628, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3625-3628.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Nonculture Prediction of Neisseria meningitidis Susceptibility to Penicillin

Aude Antignac, Jean-Michel Alonso, and Muhamed-Kheir Taha*

Unité des Neisseria, Centre National de Référence des Méningocoques, Institut Pasteur, 75724 Paris Cedex 15, France

Received 8 May 2001/Returned for modification 16 August 2001/Accepted 12 September 2001

We developed a nonculture method to predict the susceptibility of Neisseria meningitidis to penicillin G. The penA gene was amplified and submitted to restriction fragment length polymorphism analysis. This approach was first validated with a collection of 75 meningococcal strains of known phenotypes. It was next successfully applied to 29 clinical samples.


* Corresponding author. Mailing address: Unité des Neisseria, Centre National de Référence des Méningocoques, Institut Pasteur, 28 Rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: 44 (0) 1 45 68 84 38. Fax: 44 (0) 1 45 68 83 38. E-mail: mktaha{at}pasteur.fr.


Antimicrobial Agents and Chemotherapy, December 2001, p. 3625-3628, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3625-3628.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • du Plessis, M., von Gottberg, A., Cohen, C., de Gouveia, L., Klugman, K. P., for the Group for Enteric Respiratory and Meningea, (2008). Neisseria meningitidis Intermediately Resistant to Penicillin and Causing Invasive Disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46: 3208-3214 [Abstract] [Full Text]  
  • Thulin, S., Olcen, P., Fredlund, H., Unemo, M. (2008). Combined Real-Time PCR and Pyrosequencing Strategy for Objective, Sensitive, Specific, and High-Throughput Identification of Reduced Susceptibility to Penicillins in Neisseria meningitidis. Antimicrob. Agents Chemother. 52: 753-756 [Abstract] [Full Text]  
  • Taha, M.-K., Zarantonelli, M. L., Neri, A., Enriquez, R., Vazquez, J. A., Stefanelli, P. (2006). Interlaboratory Comparison of PCR-Based Methods for Detection of Penicillin G Susceptibility in Neisseria meningitidis. Antimicrob. Agents Chemother. 50: 887-892 [Abstract] [Full Text]  
  • Jorgensen, J. H., Crawford, S. A., Fiebelkorn, K. R. (2005). Susceptibility of Neisseria meningitidis to 16 Antimicrobial Agents and Characterization of Resistance Mechanisms Affecting Some Agents. J. Clin. Microbiol. 43: 3162-3171 [Abstract] [Full Text]  
  • Bryant, P. A., Li, H. Y., Zaia, A., Griffith, J., Hogg, G., Curtis, N., Carapetis, J. R. (2004). Prospective Study of a Real-Time PCR That Is Highly Sensitive, Specific, and Clinically Useful for Diagnosis of Meningococcal Disease in Children. J. Clin. Microbiol. 42: 2919-2925 [Abstract] [Full Text]  
  • Vazquez, J. A., Arreaza, L., Block, C., Ehrhard, I., Gray, S. J., Heuberger, S., Hoffmann, S., Kriz, P., Nicolas, P., Olcen, P., Skoczynska, A., Spanjaard, L., Stefanelli, P., Taha, M.-K., Tzanakaki, G. (2003). Interlaboratory Comparison of Agar Dilution and Etest Methods for Determining the MICs of Antibiotics Used in Management of Neisseria meningitidis Infections. Antimicrob. Agents Chemother. 47: 3430-3434 [Abstract] [Full Text]